Advances and Emerging Therapies in the Treatment of Non-alcoholic Steatohepatitis

Non-alcoholic steatohepatitis (NASH) now represents one of the most prevalent forms of cirrhosis and hepatocellular carcinoma. A number of treatment agents have undergone assessment in humans following promising results in animal models. Currently, about 50 therapeutic agents are in various stages o...

Descripción completa

Detalles Bibliográficos
Autores principales: Brennan, Paul N, Dillon, John F, McCrimmon, Rory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2022
Materias:
Liver Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835815/
https://www.ncbi.nlm.nih.gov/pubmed/36694893
http://dx.doi.org/10.17925/EE.2022.18.2.148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835815/
https://www.ncbi.nlm.nih.gov/pubmed/36694893
http://dx.doi.org/10.17925/EE.2022.18.2.148

Ejemplares similares